M Donald Blaufox1, Diego De Palma2, Andrew Taylor3, Zsolt Szabo4, Alain Prigent5, Martin Samal6, Yi Li7, Andrea Santos8, Giorgio Testanera9, Mark Tulchinsky10. 1. Department of Nuclear Medicine, Albert Einstein College of Medicine, and Montefiore Medical Center, New York, NY, USA. 2. Nuclear Medicine Service, ASST-Settelaghi, Varese, Italy. didepal@tin.it. 3. Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, USA. 4. The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD, USA. 5. Biophysics and Nuclear Medicine Department, Bicêtre Hospital, University of Paris-Sud, Paris, France. 6. Department of Nuclear Medicine, First Faculty of Medicine, Charles University Prague, Prague, Czech Republic. 7. Division of Nuclear Medicine, Department of Radiology, Philadelphia VA Medical Center, Philadelphia, PA, USA. 8. Hospital Cuf Descobertas, Lisbon, Portugal. 9. Barts Health NHS Trust, Department of Nuclear Medicine, St Bartholomew's Hospital, London, UK. 10. MS Hershey Medical Center, Penn State University, Hershey, PA, USA.
Abstract
PURPOSE: The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional nonprofit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. SNMMI and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine. METHODS: The SNMMI and EANM will periodically define new guidelines for nuclear medicine practice to help advance the science of nuclear medicine and to improve the quality of service to patients throughout the world. Existing practice guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary, or sooner, if indicated. CONCLUSION: Each practice guideline, representing a policy statement by the SNMMI/EANM, has undergone a thorough consensus process in which it has been subjected to extensive review. The SNMMI and EANM recognize that the safe and effective use of diagnostic nuclear medicine imaging requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guideline by entities not providing these services is not authorized.
PURPOSE: The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional nonprofit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. SNMMI and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine. METHODS: The SNMMI and EANM will periodically define new guidelines for nuclear medicine practice to help advance the science of nuclear medicine and to improve the quality of service to patients throughout the world. Existing practice guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary, or sooner, if indicated. CONCLUSION: Each practice guideline, representing a policy statement by the SNMMI/EANM, has undergone a thorough consensus process in which it has been subjected to extensive review. The SNMMI and EANM recognize that the safe and effective use of diagnostic nuclear medicine imaging requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guideline by entities not providing these services is not authorized.
Authors: A Prigent; P Cosgriff; G F Gates; G Granerus; E J Fine; K Itoh; M Peters; A Piepsz; M Rehling; M Rutland; A Taylor Journal: Semin Nucl Med Date: 1999-04 Impact factor: 4.446
Authors: M D Blaufox; M Aurell; B Bubeck; E Fommei; A Piepsz; C Russell; A Taylor; H S Thomsen; D Volterrani Journal: J Nucl Med Date: 1996-11 Impact factor: 10.057
Authors: Marshall C Strother; Eric Y Cho; Matt Loecher; David Strauss; Akhil Chandra; Elizabeth Handorf; Jian Yu; David Y T Chen; Robert Uzzo; Laura Levin; Jordan Anaokar; Alexander Kutikov Journal: Eur Urol Focus Date: 2022-02-15
Authors: Philipp E Hartrampf; Franz-Xaver Weinzierl; Sebastian E Serfling; Martin G Pomper; Steven P Rowe; Takahiro Higuchi; Anna Katharina Seitz; Hubert Kübler; Andreas K Buck; Rudolf A Werner Journal: Cancers (Basel) Date: 2022-01-27 Impact factor: 6.639
Authors: David Kersting; Miriam Sraieb; Robert Seifert; Pedro Fragoso Costa; Sandra Kazek; Lukas Kessler; Lale Umutlu; Wolfgang Peter Fendler; Walter Jentzen; Ken Herrmann; Florian Büther; Michael Nader; Christoph Rischpler Journal: Eur J Nucl Med Mol Imaging Date: 2022-04-12 Impact factor: 10.057
Authors: Camilo A Ruiz-Bedoya; Alvaro A Ordonez; Rudolf A Werner; Donika Plyku; Mariah H Klunk; Jeff Leal; Wojciech G Lesniak; Daniel P Holt; Robert F Dannals; Takahiro Higuchi; Steven P Rowe; Sanjay K Jain Journal: J Nucl Med Date: 2020-03-20 Impact factor: 11.082